| Modality | Indication | Current Stage | Development Partners | ||||
|---|---|---|---|---|---|---|---|
| Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
| Cancer | |||||||
| Vaccine | Breast Cancer |
|
|
|
|
||
| Vaccine | Ovarian Cancer |
|
|
|
|||
| Vaccine | Lung, Colon, and Prostate Cancers |
|
|
||||
| CAR-T | Ovarian Cancer |
|
|
|
|
||
| CAR-T | Other solid tumors |
|
|
||||
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...